logo
  • Home
  • News
Menu

Biogen: Beyond The New Alzheimer’s Drug

Home / Stock Analysis / Biogen: Beyond The New Alzheimer’s Drug
Article feature image

Biogen: Beyond The New Alzheimer’s Drug

12 Aug Stock Analysis

vorDa/E+ via Getty Images
Biogen (BIIB) has been in the healthcare news recently after an accelerated review by the FDA (Food & Drug Administration) approved their new Alzheimer’s therapy which drew heavy criticism from some and praise from others.
Leaving…

Click here to view the original article.

Tags:
Global, Seeking Alpha
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

1585186744718.jpeg
+

There’s Reason For Concern Over Personal Group Holdings Plc’s (LON:PGH) Massive 25% Price Jump

16 Aug Stock Analysis
1585186774276.jpeg
+

Cytek Biosciences, Inc. (NASDAQ:CTKB) Stock Catapults 26% Though Its Price And Business Still Lag The Industry

15 Aug Stock Analysis

recent post

  • federal-reserve.webp.webp

    Senator Cynthia Lummis Applauds Federal Reserve’s

    Aug 16 2025
  • new-york-bill-0-2-tax-on-crypto-nft-transactions.png

    New York Bill Proposes 0.2% Tax

    Aug 16 2025
  • investingcom_analysis_og.jpg

    Berkshire: Strategic New Positions Signal Sector

    Aug 16 2025
  • 68a06b0ce324efd0439c8fa2_68a06b0b54045dfaef8fbecd_lastImage.png

    Lessons from Gemini’s Financial Woes for

    Aug 16 2025
  • image1-133.jpg

    Best Crypto Presales to Buy in

    Aug 16 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.